Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation

Eser, Baris; Yayar, Ozlem; Buyukbakkal, Mehmet; Erdogan, Bulent; Ercan, Zafer; Merhametsiz, Ozgur; haspulat, Ayhan; Gök Oğuz, Ebru; Dogan, İbrahim; Canbakan, Basol; Deniz Ayli, M.
September 2015
Nefrologia;sep/oct2015, Vol. 35 Issue 5, p465
Background: Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone. In chronic kidney disease (CKD), circulating FGF-23 levels are markedly elevated and independently associated with mortality. Left ventricular hypertrophy (LVH) is a potent risk factor for mortality in CKD, and FGFs have been implicated in the pathogenesis of myocardial hypertrophy. In addition, the effect of anemia on CV disease and LVH is well known in CKD. A relation between iron and FGF-23 metabolism is mentioned in a few studies. The aim of this study was to test the association of FGF-23 levels with echocardiographic (ECHO) and iron parameters in peritoneal dialysis patients (PD). Methods: In this cross-sectional study, 61 subjects with PD (29 women and 32 men, mean age: 46.9±13.3 years, mean PD vintage: 69.5±39 months) underwent echocardiograms to assess left ventricular mass index (LVMI). Medical treatments and average values of the basic laboratory results of the last 6 months for all patients were recorded. Serum FGF- 23 concentrations were measured using intact FGF-23 (iFGF-23) human enzyme-linked immunosorbent assay (ELİSA) kit. According to the median levels of serum FGF-23 the patients were grouped into two (FGF-23 high and low groups). Results: Significant positive correlation was recorded between serum FGF-23 levels and LVMI (P = 0.023). There was also significant difference in terms of hemoglobin (12.1±2 versus 11.0±2, P = 0.017), transferrin saturation (TSAT) (24.9±16.8 versus 19.5±10.8, P = 0.042) between low and high FGF-23 group. Also in linear regression analysis the negative relation between FGF-23 and hemoglobin is persisted (r = 0.199, P = 0.045).


Related Articles

  • Soluble Transferrin Receptors in the diagnosis of iron deficiency anemia, β thalassemia minor and β thalassemia minor with concomitant iron deficiency anemia. Saboor, Muhammad // Pakistan Journal of Medical Sciences;2011, Vol. 27 Issue 1, p110 

    Objective: Iron deficiency anemia and β thalassemia minor are two important causes of microcytic and hypochromic anemia. β thalassemia minor with concomitant iron deficiency anemia make the diagnosis difficult through conventional laboratory tests. Determination of soluble transferrin...

  • Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation. Hu, Ming; Zhang, Zhenhui; Liu, Bin; Zhang, Shuangwei; Chai, Renjie; Chen, Xiaohua; Kong, Tianyu; Zhang, Fangcheng; Zhang, Jingzhi; Liu, Shiming; Liu, Ningning // Cellular Physiology & Biochemistry (Karger AG);Mar2018, Vol. 45 Issue 6, p2421 

    Background/Aims: Cardiac hypertrophy is a major outcome and compensatory response of the cardiovascular system to hemodynamic and additional stress responses that ultimately lead to heart failure. Auranofin (Aur) has been used for treating rheumatic arthritis for...

  • Controlled Release of Fibroblast Growth Factor 2 Stimulates Bone Healing in an Animal Model of Diabetes Mellitus. Santana, Ronaldo B.; Trackman, Philip C. // International Journal of Oral & Maxillofacial Implants;Sep/Oct2006, Vol. 21 Issue 5, p711 

    Purpose: Bone formation and the healing of calvarial defects in mice is diminished in chemically induced type 1 diabetes. The present study investigated whether controlled local release of fibroblast growth factor 2 (FGF-2) stimulates bone defect healing in this model of diabetes. Materials and...

  • The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays. Durham, Brian H.; Joseph, Frank; Bailey, Lisa M.; Fraser, William D. // Annals of Clinical Biochemistry;Sep2007, Vol. 44 Issue 5, p463 

    Background: The measurement of the serum concentration of fibroblast growth factor-23 (FGF-23) is beginning to be used as a diagnostic tool in renal phosphate wasting disorders. Having observed an increased serum FGF-23 in three subjects with low circulating ferritin concentrations we...

  • Analytical approaches to uptake and release of hydrogel-associated FGF-2. Zieris, A.; Prokoph, S.; Welzel, P. B.; Grimmer, M.; Levental, K. R.; Panyanuwat, W.; Freudenberg, U.; Werner, C. // Journal of Materials Science: Materials in Medicine;Mar2010, Vol. 21 Issue 3, p915 

    Strategies to control the delivery of growth factors are critically important in the design of advanced biomaterials. In this study we investigated the binding and release of fibroblast growth factor 2 (FGF-2) to/from a biohybrid hydrogel matrix by four independent analytical methods:...

  • Ä°ntraserebral kanamalı hastalarda serum fibroblast büyüme faktörü düzeyler. Uzar, Ertuğrul; Evliyaoğlu, Osman; Çevik, Mehmet Uğur; Arıkanoğlu, Adalet; Yücel, Yavuz; Acar, Abdullah; Ölmez, Cüneyt; Kamaşak, Kağan // Journal of Clinical & Experimental Investigations / Klinik ve De;2011, Vol. 2 Issue 3, p282 

    Objectives: Intracerebral hemorrhage (ICH) is one of the most mortal subtypes of stroke. Due to the angiogenic, neurotropic, and vessel-dilating properties of basic fibroblast growth factor (bFGF) in the brain, role of bFGF has been investigated in a number of neurological disorders. So far,...

  • Basic fibroblast growth factor and estradiol for the diagnosis of infantile hemangiomas and vascular malformations. YANG Xiu-juan; ZHENG Jia-wei; HONG Li; ZHOU Qin; QIN Zhong-ping // China Journal of Oral & Maxillofacial Surgery;2009, Vol. 7 Issue 6, p482 

    PURPOSE: To investigate the significance of serum basic fibroblast growth factor (bFGF), estradiol (E2) and urinary bFGF in differentiating infantile hemangiomas from vascular malformations. METHODS: Between October 2007 and January 2009, 96 patients with hemangiomas and 25 patients with...

  • Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study. Otani, Makoto; Takimoto, Yoshiyuki; Moriya, Junko; Yoshiuchi, Kazuhiro; Akabayashi, Akira // BioPsychoSocial Medicine;2011, Vol. 5 Issue 1, p7 

    Fibroblast growth factor (FGF) 23, a circulating 26-kDa peptide produced by osteogenic cells, is a novel phosphaturic factor. In our previous study, binge-eating/purging type anorexia nervosa (AN-BP) patients had elevated plasma intact FGF23 (iFGF23) levels, while restricting type (AN-R)...

  • Fibroblast growth factor 23. Smith, Edward R; McMahon, Lawrence P; Holt, Stephen G // Annals of Clinical Biochemistry;Mar2014, Vol. 51 Issue 2, p203 

    There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics